Diamicron MR 60mg

  • Name:

    Diamicron MR 60mg

  • Company:
    info
  • Active Ingredients:

    Gliclazide

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 31/05/16

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 31/5/2016
print

Print ViewKeyword Search SmPC

Servier Laboratories Ireland Ltd

Servier Laboratories Ireland Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name ACERYCAL Active Ingredients Amlodipine besilate, Perindopril arginine
Medicine Name Cosimprel 10mg/10mg film-coated tablets Active Ingredients Bisoprolol Fumarate, Perindopril arginine
Medicine Name Cosimprel 10mg/5mg film-coated tablets Active Ingredients Bisoprolol Fumarate, Perindopril arginine
Medicine Name Cosimprel 5mg/10mg film-coated tablets Active Ingredients Bisoprolol Fumarate, Perindopril arginine
Medicine Name Cosimprel 5mg/5mg film-coated tablets Active Ingredients Bisoprolol Fumarate, Perindopril arginine
Medicine Name Coverdine Active Ingredients Amlodipine, Indapamide, Perindopril
Medicine Name Coversyl Arginine 10mg Active Ingredients Perindopril arginine
Medicine Name Coversyl Arginine 10mg orodispersible tablets Active Ingredients Perindopril arginine
Medicine Name Coversyl Arginine 5mg Active Ingredients Perindopril arginine
Medicine Name Coversyl Arginine 5mg orodispersible tablets Active Ingredients Perindopril arginine
Medicine Name Coversyl Arginine Plus 10mg/2.5mg film-coated tablets Active Ingredients Indapamide, Perindopril arginine
Medicine Name Coversyl Arginine Plus 2.5mg/0.625mg film-coated tablets Active Ingredients Indapamide, Perindopril arginine
Medicine Name Coversyl Arginine Plus 5 mg/1.25 mg film-coated tablets Active Ingredients Indapamide, Perindopril arginine
Medicine Name Diamicron MR 30 mg Active Ingredients Gliclazide
Medicine Name Diamicron MR 60mg Active Ingredients Gliclazide
Medicine Name LIPOCOMB Active Ingredients ezetimibe, Rosuvastatin Calcium
Medicine Name LONSURF Active Ingredients Tipiracil hydrochloride, Trifluridine
Medicine Name Lonsurf 15mg/6.14mg, 20mg/8.19mg film-coated tablets Active Ingredients Tipiracil hydrochloride, Trifluridine
Medicine Name Natrilix SR Active Ingredients Indapamide
Medicine Name Oncaspar (solution) Active Ingredients pegaspargase
Medicine Name Oncaspar Lyophilisate (Powder) Active Ingredients pegaspargase
Medicine Name Pixuvri 29 mg Active Ingredients Pixantrone dimaleate
Medicine Name Procoralan film-coated tablets Active Ingredients Ivabradine hydrochloride
Medicine Name Protelos 2 g granules for oral suspension Active Ingredients Strontium Ranelate
Medicine Name Valdoxan 25mg Film-coated Tablets Active Ingredients Agomelatine
1 - 0 of 26 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 31 May 2016 PIL

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Free text change information supplied by the pharmaceutical company

  Correction of sulphonylurea by sulfonylurea in sections 4.2, 4.3, 4.8, 5.1.

  Addition of St. John's Wort (Hypericum perforatum) preparations in sections 4.4 and 4.5 as products that may cause an increase in blood glucose levels.

  Addition of dysglycaemia section in 4.4.

  Addition of fluroniquinolones in section 4.5 as products that may cause dysglycaemia.

Updated on 31 May 2016 SmPC

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

  Correction of sulphonylurea by sulfonylurea in sections 4.2, 4.3, 4.8, 5.1.

  Addition of St. John's Wort (Hypericum perforatum) preparations in sections 4.4 and 4.5 as products that may cause an increase in blood glucose levels.

  Addition of dysglycaemia section in 4.4.

  Addition of fluroniquinolones in section 4.5 as products that may cause dysglycaemia.

Updated on 31 May 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 31 May 2016 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 17 June 2015 PIL

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation

Free text change information supplied by the pharmaceutical company

Date of Renewal of Authorisation: 20th May 2015

Updated on 17 June 2015 SmPC

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Date of Renewal of Authorisation: 20th May 2015

Updated on 9 October 2012 PIL

Reasons for updating

  • New SPC for medicines.ie

Free text change information supplied by the pharmaceutical company

None provided

Updated on 9 October 2012 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

None provided